These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22403511)

  • 1. Induction of donor-specific tolerance: is this achievable?
    Cho EJ; Park JI; An JN; Kim YS
    Korean J Intern Med; 2012 Mar; 27(1):114. PubMed ID: 22403511
    [No Abstract]   [Full Text] [Related]  

  • 2. Innate Allorecognition and Memory in Transplantation.
    Zhao D; Abou-Daya KI; Dai H; Oberbarnscheidt MH; Li XC; Lakkis FG
    Front Immunol; 2020; 11():918. PubMed ID: 32547540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bibliography. Current world literature. Histocompatibility.
    Curr Opin Organ Transplant; 2008 Aug; 13(4):467-76. PubMed ID: 18688955
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory T cells in transplantation.
    Wood KJ
    Transplant Proc; 2011; 43(6):2135-6. PubMed ID: 21839214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand.
    Spencer CT; Gilchuk P; Dragovic SM; Joyce S
    Curr Opin Organ Transplant; 2010 Aug; 15(4):512-25. PubMed ID: 20616723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bibliography. Current world literature. Tolerance induction.
    Curr Opin Organ Transplant; 2008 Aug; 13(4):453-9. PubMed ID: 18685346
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolerance induction.
    Kupiec-Weglinski JW
    Curr Opin Organ Transplant; 2008 Aug; 13(4):331-2. PubMed ID: 18685325
    [No Abstract]   [Full Text] [Related]  

  • 8. The Importance of Bringing Transplantation Tolerance to the Clinic.
    Cosimi AB; Ascher NL; Emond JC; Kaufman DB; Madsen JC; Miller J; Monaco AP; Montgomery RA; Newell KA; Sánchez-Fueyo A; Sarwal MM; Scandling JD; Strober S; Todo S; Weir MR; Sachs DH
    Transplantation; 2021 May; 105(5):935-940. PubMed ID: 33901128
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathways of allorecognition: implications for transplantation tolerance.
    Game DS; Lechler RI
    Transpl Immunol; 2002 Aug; 10(2-3):101-8. PubMed ID: 12216939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Sensitization and Desensitization in Organ Transplantation.
    Anwar IJ; Jackson AM; Locke JE; Kwun J
    Front Immunol; 2021; 12():784472. PubMed ID: 34721444
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental and clinical tolerance induction.
    Hardy MA; Agrawal S; Suciu-Foca N
    Transplant Proc; 1998 Aug; 30(5):2435-7. PubMed ID: 9723528
    [No Abstract]   [Full Text] [Related]  

  • 12. Current world literature.
    Curr Opin Organ Transplant; 2011 Aug; 16(4):444-52. PubMed ID: 21753710
    [No Abstract]   [Full Text] [Related]  

  • 13. Transplantation: moving to the next level.
    Sykes M
    Immunol Rev; 2014 Mar; 258(1):5-11. PubMed ID: 24517422
    [No Abstract]   [Full Text] [Related]  

  • 14. Some observations on prope tolerance.
    Calne R; Watson CJ
    Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways of major histocompatibility complex allorecognition.
    Afzali B; Lombardi G; Lechler RI
    Curr Opin Organ Transplant; 2008 Aug; 13(4):438-44. PubMed ID: 18685342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance: one transplant for life.
    Kawai T; Leventhal J; Madsen JC; Strober S; Turka LA; Wood KJ
    Transplantation; 2014 Jul; 98(2):117-21. PubMed ID: 24926829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A "new" road to tolerance: clonal deletion and drugs added when needed (DAWN).
    Terasaki PI; Everly ML; Kaneku H; Hoshino J; Vanikar AV; Patel HV; Shah PR; Trivedi HL
    Clin Transpl; 2010; ():253-60. PubMed ID: 21698835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for persisting antigen, antigen presentation, and ICAM-1 in increased renal graft survival after oral or portal vein donor-specific immunization.
    Gorczynski RM; Chen Z; Zeng H; Fu XM
    Transplantation; 1998 Aug; 66(3):339-49. PubMed ID: 9721803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-derived alloantigen-presenting cells persist in the liver allograft during tolerance induction.
    Meyer D; Löffeler S; Otto C; Czub S; Gassel HJ; Timmermann W; Thiede A; Ulrichs K
    Transpl Int; 2000; 13(1):12-20. PubMed ID: 10743684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients.
    Everly MJ
    Clin Transpl; 2011; ():333-6. PubMed ID: 22755427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.